The commercial significance of CIS markets is increasing – Russia now accounts for two-fifths of the entire Central and Eastern Europe pharmaceutical market. It is crucial that pharmaceutical companies keep up-to-date with the latest regulatory developments to ensure their place on the CIS market.
Using a combination of theory and practical case studies, the course will allow delegates to develop the knowledge needed to successfully navigate the pharmaceutical market in Russia and other key CIS countries.
Book before the 20th February 2014: £1395 + 20% VAT = £1674
Book after the 20th February 2014: £1495 + 20% VAT = £1794